Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
BCBS Kansas City Medical Policy Updates – July 2018
Click here to view the Blue Cross Blue Shield Kansas City Medical Policy Updates »
July 2018 Medical Policy Updates:
- Actigraphy
- Allergy Testing and Allergy Immunotherapy
- Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias
- Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
- Austedo (deutetrabenazine)
- Automated Point-of-Care Nerve Conduction Tests
- Bavencio (avelumab)
- Biofeedback as a Treatment of Chronic Pain
- Biofeedback as a Treatment of Fecal Incontinence or Constipation
- Biofeedback as a Treatment of Headache
- Chromoendoscopy as an Adjunct to Colonoscopy
- Crysvita (burosumab-twza)
- Diagnosis and Treatment of Sacroiliac Joint Pain
- Dynamic Posturography
- Epclusa (sofosbuvir/velpatasvir)
- Erythropoiesis-Stimulating Agents
- Fecal Analysis in the Diagnosis of Intestinal Dysbiosis
- Fecal Microbiota Transplantation
- Forms of Alternative Treatment
- Gabapentin Step Therapy Program
- General Approach to Evaluating the Utility of Genetic Panels
- Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer
- Genetic Cancer Susceptibility Panels Using Next Generation Sequencing
- Glucagon-Like Peptide-1 (GLP-1) Agonists
- Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
- Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
- Hematopoietic Cell Transplantation for CNS Embryonal Tumors and Ependymoma
- Hematopoietic Cell Transplantation for Non-Hodgkin’s Lymphomas
- Hematopoietic Cell Transplantation for Solid Tumors of Childhood
- Hematopoietic Cell Transplantation in the Treatment of Germ Cell Tumors (GCT)
- Hip Resurfacing
- Hippotherapy
- Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease
- Ilaris (canakinumab for subcutaneous [SC] injection -Novartis)
- IMFINZI (durvalumab)
- Immunizations
- Ingrezza (valbenazine)
- Kalbitor (ecallantide injection for subcutaneous use)
- Kisqali and Kisqali Femara Co-Pack
- Lemtrada (alemtuzumab)
- Magnetoencephalography – Magnetic Source Imaging
- Maternity – Global Fee, Inclusions and Exclusions
- Meniscal Allograft and Other Meniscus Implants
- Miscellaneous Investigational Procedures
- Molecular Testing in the Management of Pulmonary Nodules
- Myalept (metreleptin)
- Non-Contact Ultrasound Treatment for Wounds
- Non-Invasive Vascular Studies
- Northera (droxidopa)
- Outpatient Pulmonary Rehabilitation
- Plugs for Anal Fistula Repair
- Prolotherapy
- Provigil (modafinil) / Nuvigil (armodafinil)
- Quantitative Sensory Testing
- Reduction Mammaplasty for Breast-Related Symptoms
- Retinal Telescreening for Diabetic Retinopathy
- Sphenopalatine Ganglion Block or Other Intranasal Blockage for Headache
- Sublingual Immunotherapy as a Technique of Allergen Specific Therapy
- Symdeko (tezacaftor/ivacaftor)
- Tavalisse (fostamatinib disodium hexahydrate)
- Topical Immunomodulator Step Therapy Program
- Topical Tazarotene
- Transanal Endoscopic Microsurgery (TEM)
- Whole Gland Cryoablation of Prostate Cancer
- Xermelo (telotristat)
- Xolair (omalizumab injection for subcutaneous [SC] use)
- Zejula (niraparib)
- Zepatier® (grazoprevir/elbasvir tablets)
- Zetia Step Therapy Program
Click here to view the Blue Cross Blue Shield Kansas City Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
